SynthesisAgeing research reviews2021

Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease.

Konstantinos I Avgerinos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.